Clinical Trials

NCT04260867 | ACTIVE_NOT_RECRUITING | NA
111 participants

Essential Oils for Electrocautery

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-01
Start Date:
2020-12-22
Completion:
2021-06-01
Conditions
  • Anxiety
Interventions
  • OTHER
No Results Yet
NCT04227028 | ACTIVE_NOT_RECRUITING | PHASE1
5 participants

Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-01
Start Date:
2020-03-09
Completion:
2027-03-25
Conditions
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • Metastatic Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT04195555 | ACTIVE_NOT_RECRUITING | PHASE2
3 participants

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-01
Start Date:
2020-07-20
Completion:
2025-03-31
Conditions
  • Recurrent Ependymoma
  • Recurrent Ewing Sarcoma
  • Recurrent Hepatoblastoma
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Malignant Germ Cell Tumor
  • Recurrent Malignant Glioma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Medulloblastoma
  • Recurrent Neuroblastoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Osteosarcoma
  • Recurrent Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Rhabdoid Tumor
  • Recurrent Rhabdomyosarcoma
  • Recurrent Soft Tissue Sarcoma
  • Recurrent WHO Grade 2 Glioma
  • Refractory Ependymoma
  • Refractory Ewing Sarcoma
  • Refractory Hepatoblastoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Malignant Germ Cell Tumor
  • Refractory Malignant Glioma
  • Refractory Malignant Solid Neoplasm
  • Refractory Medulloblastoma
  • Refractory Neuroblastoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Osteosarcoma
  • Refractory Peripheral Primitive Neuroectodermal Tumor
  • Refractory Rhabdoid Tumor
  • Refractory Rhabdomyosarcoma
  • Refractory Soft Tissue Sarcoma
  • Refractory WHO Grade 2 Glioma
  • Wilms Tumor
Interventions
  • DRUG
NCT04018859 | ACTIVE_NOT_RECRUITING | PHASE2
11 participants

Platelet-rich Plasma for Eyebrows

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-01
Start Date:
2019-09-25
Completion:
2027-05-31
Conditions
  • Eyebrow Hypotrichosis
Interventions
  • DEVICE
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page